Drug Application Partner

Accelerate Your Drug Development Timeline to NDA

Quotient Sciences will help you accelerate timelines. Taking your molecule through proof-of-concept to new drug application and beyond.

Looking to accelerate your drug candidates' development timeline to the New Drug Application (NDA) stage? Quotient Sciences' drug development experts are ready to help discuss your needs.

Quotient Sciences understand that getting molecules to proof-of-concept (POC) and new drug application (NDA) are key milestones in the development of a new drug candidate. That is why we offer our fully integrated capabilities including our unique Translational Pharmaceutics® platform to reach those milestones faster. From first-in-human testing to seamless drug product supply for patient trials and drug optimization, we operate a cost-effective process that accelerates molecules through key milestones, faster.

Contact our experts

Accelerating Early Candidate Development

Simplify early development and accelerate to proof-of-concept and New Drug Application.

POC to NDA Partner

From your molecule discovery to proof-of-concept (POC) to New Drug Application (NDA), Quotient Sciences are well equipped to partner with you to accelerate your drug approval process and reach your key milestones.

We have over 30 years of success at simplifying the early development to proof-of-concept of molecules, a key milestone in the development of a new drug candidate. At the same time, we also understand the transition to POC & NDA needs to be fast and cost-effective.

Contact our experts

Quotient Sciences can help address the most critical challenges in the drug development process from proof-of-concept to new drug application. Contact us today to learn how we can help accelerate your program.

We respect your privacy. Find out how we handle your personal information in our privacy policy.
Get in touch
Our experts have insight into a variety of subjects. We are here to help.
Ask the Experts